Edition:
United States

CTI Biopharma Corp (CTIC.OQ)

CTIC.OQ on NASDAQ Stock Exchange Capital Market

2.24USD
3:39pm EDT
Change (% chg)

$0.29 (+14.87%)
Prev Close
$1.95
Open
$1.95
Day's High
$2.26
Day's Low
$1.88
Volume
118,709
Avg. Vol
167,557
52-wk High
$5.36
52-wk Low
$1.70

Chart for

About

CTI BioPharma Corp. (CTI), formerly Cell Therapeutics, Inc., is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers. The Company is focused on commercializing PIXUVRI... (more)

Overall

Beta: -0.63
Market Cap(Mil.): $113.08
Shares Outstanding(Mil.): 57.99
Dividend: --
Yield (%): --

Financials

  CTIC.OQ Industry Sector
P/E (TTM): -- 109.17 32.55
EPS (TTM): -0.89 -- --
ROI: -58.80 1.47 12.80
ROE: -73.82 0.22 14.92

BRIEF-Cti Biopharma Reports Q1 EPS Loss Per Share Of $0.08

* AS OF MARCH 31, 2018, CASH AND CASH EQUIVALENTS TOTALED $104.6 MILLION, COMPARED TO $43.2 MILLION AS OF DECEMBER 31, 2017 Source text for Eikon: Further company coverage:

May 03 2018

Earnings vs. Estimates